US 11261188
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
granted A61KA61K31/437A61K31/4985
Quick answer
US patent 11261188 (Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel) held by PRAXIS PRECISION MEDICINES, INC. expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRAXIS PRECISION MEDICINES, INC.
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/437, A61K31/4985, A61K31/5025, A61K31/519